Vaxart, Inc. - Common Stock
Long
Aggiornato

At Long Term Support. Revenue Beat. 682% Upside.

We are right at the support line spanning across 5 years. With revenue beat and 682% upside (average price target), it looks like a safe buy. I hold stocks and April 2025 calls.
Trade attivo
Fib level .382 roughly coincides with the analyst's average price target.
Nota
Still above the trend line.
Nota
Above 50 SMA yet again on the weekly. Not it should stay there and challenge 200 SMA.

istantanea
Nota
Note: It has made multiple attempts in the past to challenge the 50 SMA but has failed. However, the base held (yellow line).

Declinazione di responsabilità